Trial Profile
Randomized Phase II Trial of Neoadjuvant Docetaxel Plus Cisplatin and 5-Fluorouracil Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2010
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Jul 2008 Final results reported at ASCO 2008 (1113304).
- 14 Dec 2006 Status change
- 14 Sep 2006 New trial record.